These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 26713736)
1. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells. Otoshi T; Tanaka T; Morimoto K; Nakatani T PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019 [TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival. Zhang X; Ren J; Yan L; Tang Y; Zhang W; Li D; Zang Y; Kong F; Xu Z PLoS One; 2015; 10(3):e0118659. PubMed ID: 25751257 [TBL] [Abstract][Full Text] [Related]
4. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells. Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500 [TBL] [Abstract][Full Text] [Related]
5. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells. Chen LC; Liu HP; Li HP; Hsueh C; Yu JS; Liang CL; Chang YS Oncogene; 2009 Apr; 28(17):1904-15. PubMed ID: 19330019 [TBL] [Abstract][Full Text] [Related]
6. Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression. Barboro P; Ferrari N; Balbi C Cancer Lett; 2014 Oct; 352(2):152-9. PubMed ID: 25016060 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis. Gao R; Yu Y; Inoue A; Widodo N; Kaul SC; Wadhwa R J Biol Chem; 2013 May; 288(21):15046-56. PubMed ID: 23564449 [TBL] [Abstract][Full Text] [Related]
8. Cellular nucleic acid binding protein suppresses tumor cell metastasis and induces tumor cell death by downregulating heterogeneous ribonucleoprotein K in fibrosarcoma cells. Qiu J; Chen S; Su L; Liu J; Xiao N; Ou TM; Tan JH; Gu LQ; Huang ZS; Li D Biochim Biophys Acta; 2014 Jul; 1840(7):2244-52. PubMed ID: 24594223 [TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma. Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-delta mediates down-regulation of heterogeneous nuclear ribonucleoprotein K protein: involvement in apoptosis induction. Gao FH; Wu YL; Zhao M; Liu CX; Wang LS; Chen GQ Exp Cell Res; 2009 Nov; 315(19):3250-8. PubMed ID: 19747914 [TBL] [Abstract][Full Text] [Related]
11. Compartmentalization of hnRNP-K during cell cycle progression and its interaction with calponin in the cytoplasm. Laury-Kleintop LD; Tresini M; Hammond O J Cell Biochem; 2005 Aug; 95(5):1042-56. PubMed ID: 15962305 [TBL] [Abstract][Full Text] [Related]
12. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
13. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas. Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53. Zhou R; Shanas R; Nelson MA; Bhattacharyya A; Shi J Int J Cancer; 2010 Jan; 126(2):395-404. PubMed ID: 19609950 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Chen LC; Hsueh C; Tsang NM; Liang Y; Chang KP; Hao SP; Yu JS; Chang YS Clin Cancer Res; 2008 Jun; 14(12):3807-13. PubMed ID: 18559600 [TBL] [Abstract][Full Text] [Related]
17. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma. Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919 [TBL] [Abstract][Full Text] [Related]
18. Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression. Suk FM; Lin SY; Lin RJ; Hsine YH; Liao YJ; Fang SU; Liang YC Oncotarget; 2015 Sep; 6(28):25988-6001. PubMed ID: 26317903 [TBL] [Abstract][Full Text] [Related]
19. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells. Rosendahl AH; Forsberg G Kidney Int; 2006 Nov; 70(9):1584-90. PubMed ID: 16969385 [TBL] [Abstract][Full Text] [Related]
20. hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors. Xiao Z; Ko HL; Goh EH; Wang B; Ren EC Carcinogenesis; 2013 Jul; 34(7):1458-67. PubMed ID: 23455382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]